Trauma-Induced Coagulopathy-A Review of the Systematic Reviews: Is There Sufficient Evidence to Guide Clinical Transfusion Practice?

被引:30
作者
Curry, Nicola [1 ,2 ]
Stanworth, Simon
Hopewell, Sally
Doree, Carolyn
Brohi, Karim
Hyde, Chris
机构
[1] Oxford Radcliffe Hosp NHS Trust, NHS Blood & Transplant, Oxford OX3 9BQ, England
[2] Univ Oxford, Oxford OX3 9BQ, England
关键词
RECOMBINANT-FACTOR-VIIA; ACTIVATED FACTOR-VII; RED-BLOOD-CELLS; FRESH-FROZEN PLASMA; MASSIVE TRANSFUSION; CONTROL RESUSCITATION; MORTALITY; RATIO; EFFICACY; COAGULATION;
D O I
10.1016/j.tmrv.2011.01.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systematic reviews are accepted as a robust and less biased means of appraising and synthesizing results from high-quality studies. This report collated and summarized all the systematic review evidence relating to the diagnosis and management of trauma-related coagulopathy and transfusion, thereby covering the widest possible body of literature. We defined 4 key clinical questions: (1) What are the best methods of predicting and diagnosing traumarelated coagulopathy? (2) Which methods of clinical management correct coagulopathy? (3) Which methods of clinical management correct bleeding? and (4) What are the outcomes of transfusion in trauma? Thirty-seven systematic reviews were identified through searches of MEDLINE (1950-July 2010), EMBASE (1980-July 2010), The Cochrane Library (Issue 7, 2010), National Guidelines Clearing House, National Library for Health Guidelines Finder, and UKBTS SRI Transfusion Evidence Library (www.transfusionevidencelibrary.com). The evidence from the systematic review literature was scanty with many gaps, and we were not able to conclusively answer any of our 4 questions. Much more needs to be understood about how coagulopathy and bleeding in trauma are altered by transfusion practices and, most importantly, whether this translates into improved survival. There is a need for randomized controlled trials to answer these questions. The approach described in this report provides a framework for incorporating new evidence. (C) 2011 Published by Elsevier Inc.
引用
收藏
页码:217 / 231
页数:15
相关论文
共 74 条
[1]  
[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004896
[2]  
[Anonymous], EXPRESSBRIEFS
[3]  
[Anonymous], COCHRANE HDB SYSTEMA
[4]  
[Anonymous], 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002245
[5]  
[Anonymous], CAUS SPEC MORT MORB
[6]   A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients [J].
Barletta, JF ;
Ahrens, CL ;
Tyburski, JG ;
Wilson, RF .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 58 (03) :646-651
[7]   Evidence for the use of recombinant factor VIIa in the prevention and treatment of bleeding in patients without hemophilia [J].
Birchall, Janet ;
Stanworth, Simon J. ;
Duffy, Michael R. ;
Doree, Carolyn J. ;
Hyde, Christopher .
TRANSFUSION MEDICINE REVIEWS, 2008, 22 (03) :177-187
[8]   Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials [J].
Boffard, KD ;
Riou, B ;
Warren, B ;
Choong, PIT ;
Rizoli, S ;
Rossaint, R ;
Axelsen, M ;
Kluger, Y .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (01) :8-16
[9]   RETRACTED: Fluid choice for resuscitation of the trauma patient: a review of the physiological, pharmaco-logical, and clinical evidence (Retracted Article) [J].
Boldt, J .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2004, 51 (05) :500-513
[10]   The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital [J].
Borgman, Matthew A. ;
Spinella, Philip C. ;
Perkins, Jeremy G. ;
Grathwohl, Kurt W. ;
Repine, Thomas ;
Beekley, Alec C. ;
Sebesta, James ;
Jenkins, Donald ;
Wade, Charles E. ;
Holcomb, John B. .
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2007, 63 (04) :805-813